"There are no catalysts to take this lower prior to the approval of Afrezza which could happen by next September."
"There are any number of realistic catalysts that could gap it higher overnight."
"$4.00-$6.00 by approval."
Just a thought!!!
p.s. My choice for a partner is still Sanofi.
Are you IN or OUT today ?
I forsee good news and the stock will go up $2.50 after conf. call.
Sentiment: Strong Buy
Overdue for a positive article on SeekingAlpha.
Probably after the conference call.